- Home
- INDP vs CDIO Comparison
INDP vs CDIO Comparison
Compare INDP & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- CDIO
- Stock Information
- Founded
- INDP 2000
- CDIO 2017
- Country
- INDP United States
- CDIO United States
- Employees
- INDP N/A
- CDIO N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- INDP Health Care
- CDIO Health Care
- Exchange
- INDP Nasdaq
- CDIO Nasdaq
- Market Cap
- INDP 6.0M
- CDIO 6.4M
- IPO Year
- INDP N/A
- CDIO N/A
- Fundamental
- Price
- INDP $2.40
- CDIO $3.90
- Analyst Decision
- INDP Strong Buy
- CDIO
- Analyst Count
- INDP 2
- CDIO 0
- Target Price
- INDP $238.00
- CDIO N/A
- AVG Volume (30 Days)
- INDP 77.0K
- CDIO 25.4K
- Earning Date
- INDP 08-13-2025
- CDIO 08-14-2025
- Dividend Yield
- INDP N/A
- CDIO N/A
- EPS Growth
- INDP N/A
- CDIO N/A
- EPS
- INDP N/A
- CDIO N/A
- Revenue
- INDP N/A
- CDIO $19,507.00
- Revenue This Year
- INDP N/A
- CDIO $1,434.82
- Revenue Next Year
- INDP N/A
- CDIO $4,661.91
- P/E Ratio
- INDP N/A
- CDIO N/A
- Revenue Growth
- INDP N/A
- CDIO N/A
- 52 Week Low
- INDP $2.47
- CDIO $3.22
- 52 Week High
- INDP $58.24
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- INDP 18.11
- CDIO 51.65
- Support Level
- INDP $6.26
- CDIO $3.58
- Resistance Level
- INDP $6.65
- CDIO $3.98
- Average True Range (ATR)
- INDP 0.69
- CDIO 0.24
- MACD
- INDP -0.33
- CDIO 0.03
- Stochastic Oscillator
- INDP 1.86
- CDIO 77.74
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.